Dare Bioscience Stock Performance
| DARE Stock | USD 3.25 0.06 1.88% |
On a scale of 0 to 100, Dare Bioscience holds a performance score of 10. The firm shows a Beta (market volatility) of -0.0384, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Dare Bioscience are expected to decrease at a much lower rate. During the bear market, Dare Bioscience is likely to outperform the market. Please check Dare Bioscience's sortino ratio, semi variance, rate of daily change, as well as the relationship between the value at risk and kurtosis , to make a quick decision on whether Dare Bioscience's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Dare Bioscience are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Dare Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 10.8 M |
Dare Bioscience Relative Risk vs. Return Landscape
If you would invest 288.00 in Dare Bioscience on March 14, 2025 and sell it today you would earn a total of 37.00 from holding Dare Bioscience or generate 12.85% return on investment over 90 days. Dare Bioscience is currently generating 0.2044% in daily expected returns and assumes 1.5864% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of stocks are less volatile than Dare, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Dare Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dare Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dare Bioscience, and traders can use it to determine the average amount a Dare Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1288
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DARE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.59 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.2 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Dare Bioscience is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dare Bioscience by adding it to a well-diversified portfolio.
Dare Bioscience Fundamentals Growth
Dare Stock prices reflect investors' perceptions of the future prospects and financial health of Dare Bioscience, and Dare Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dare Stock performance.
| Return On Equity | -9.95 | ||||
| Return On Asset | -0.87 | ||||
| Operating Margin | (180.17) % | ||||
| Current Valuation | 21.48 M | ||||
| Shares Outstanding | 8.85 M | ||||
| Price To Earning | (43.44) X | ||||
| Price To Book | 10.75 X | ||||
| Price To Sales | 1,090 X | ||||
| Revenue | 9.78 K | ||||
| EBITDA | (23.41 M) | ||||
| Cash And Equivalents | 40.39 M | ||||
| Cash Per Share | 0.48 X | ||||
| Total Debt | 1.3 M | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | (1.08) X | ||||
| Cash Flow From Operations | 5.39 M | ||||
| Earnings Per Share | (0.17) X | ||||
| Total Asset | 22.1 M | ||||
| Retained Earnings | (175.29 B) | ||||
| Current Asset | 7.58 M | ||||
| Current Liabilities | 17.82 M | ||||
About Dare Bioscience Performance
By analyzing Dare Bioscience's fundamental ratios, stakeholders can gain valuable insights into Dare Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dare Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dare Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for womens health in the United States. Dar Bioscience, Inc. is headquartered in San Diego, California. Dare Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.Things to note about Dare Bioscience performance evaluation
Checking the ongoing alerts about Dare Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dare Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 9.78 K. Net Loss for the year was (4.05 M) with loss before overhead, payroll, taxes, and interest of (13.22 M). | |
| Dare Bioscience has a frail financial position based on the latest SEC disclosures |
- Analyzing Dare Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dare Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Dare Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dare Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dare Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dare Bioscience's stock. These opinions can provide insight into Dare Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Dare Stock analysis
When running Dare Bioscience's price analysis, check to measure Dare Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dare Bioscience is operating at the current time. Most of Dare Bioscience's value examination focuses on studying past and present price action to predict the probability of Dare Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dare Bioscience's price. Additionally, you may evaluate how the addition of Dare Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world |